Health Condition 1: L811- Chloasma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants of any gender in the age group of 18-60 years. Participants having bilateral symmetrical or asymmetrical brown macules on face (nose, forehead, upper lip and cheeks & chin ). Participants who are willing to participate and comply with the protocol and to sign IEC approved ICF.
Exclusion criteria
Exclusion criteria: The following participants will be excluded from the study: Participants aged less than 18 and more than 60 years. Pregnant and lactating women. Known cases of significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction, Malignancy, Endocrine disorders, HIV infection, AIDS, etc. Known allergy, sensitivity or intolerance to the study drug or any of its ingredients Participants with active alcohol intake and/or drug abuse Those unwillingly to come for regular follow-up for the entire duration of the study and any patient considered not eligible in the investigator’s discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 25 % reduction in MASI Score from baselineTimepoint: At baseline 2nd, 4th, 6th and on 8th Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Melasma Quality of LifeTimepoint: At baseline and on 8th Week | — |
Countries
India
Contacts
NATIONAL RESEARCH INSTITUTE OF UNANI MEDICINE FOR SKIN DISORDERS